Cargando…
Controlling the receptor for advanced glycation end‐products to conquer diabetic vascular complications
Diabetic vascular complications, such as cardiovascular disease, stroke and microangiopathy, lead to high rates of morbidity and mortality in patients with long‐term diabetes. Extensive intracellular and extracellular formation of advanced glycation end‐products (AGE) is considered a causative facto...
Autores principales: | Yamamoto, Yasuhiko, Yamamoto, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020727/ https://www.ncbi.nlm.nih.gov/pubmed/24843553 http://dx.doi.org/10.1111/j.2040-1124.2011.00191.x |
Ejemplares similares
-
Receptor for advanced glycation end‐products‐mediated inflammation and diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2011) -
The Role of Advanced Glycation End Products in Diabetic Vascular Complications
por: Rhee, Sang Youl, et al.
Publicado: (2018) -
Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014) -
Receptor for advanced glycation end-products and child neglect in mice: A possible link to postpartum depression
por: Higashida, Haruhiro, et al.
Publicado: (2022) -
Neuroprotective Effects of Endogenous Secretory Receptor for Advanced Glycation End-products in Brain Ischemia
por: Shimizu, Yu, et al.
Publicado: (2019)